Scorpius Highlighted In Drug Development & Delivery's Annual Report

July 21, 2023

Scorpius BioManufacturing was recently highlighted in a special report from Drug Development & Delivery. The report details how "leading CDMOs from around the globe describe their unique de­velopment and manufacturing capabilities and technologies, and present real-world examples of how they have put these to use to produce innovative compounds, lower development costs, and shorten time to market."

Steve Lavezoli, VP of Business Development at Scorpius, was asked how CDMOs can develop better partnerships with drug sponsors and mold themselves to client business models to accelerate development. His response highlights the importance of:


  1. Flexibility
  2. Facility design best practices
  3. Responsiveness


To read the full commentary from Scorpius, visit Drug Development & Delivery's "SPECIAL FEATURE – Outsourcing Formulation Development & Manufacturing: Putting Customers First."